Interpretation of Low TSH with Normal Free T4

Diagnostic Classification

Subclinical hyperthyroidism is defined as a serum TSH concentration below the reference range with normal free T4 levels, as seen in this thyroid panel with a TSH of 0.120 uIU/mL and free T4 of 0.84 ng/dL 1
The normal free T4 with suppressed TSH distinguishes subclinical hyperthyroidism from overt hyperthyroidism, which would show both low TSH and elevated free T4 1

Endogenous causes of subclinical hyperthyroidism include early Graves' disease 1 and toxic nodular goiter 1
Exogenous or other causes of subclinical hyperthyroidism include excessive thyroid hormone replacement therapy 1, recovery phase after treatment for hyperthyroidism 1, normal pregnancy 1, nonthyroidal illness (euthyroid sick syndrome) 1, and medication effects (dopamine, glucocorticoids, dobutamine) 1

Patients with TSH between 0.1-0.45 mIU/L have a lower likelihood of progression to overt hyperthyroidism compared to those with TSH <0.1 mIU/L 2
Prolonged subclinical hyperthyroidism increases the risk for atrial fibrillation and cardiac arrhythmias, especially in elderly patients 3, bone mineral density loss and increased fracture risk 3, and potential increased cardiovascular mortality 4

Confirm the finding with repeat thyroid function tests (TSH and free T4) within 4 weeks 3
If the patient has cardiac disease, atrial fibrillation, or other serious medical conditions, repeat testing should occur within 2 weeks 3
Further evaluation to establish the etiology should include a detailed medication history to rule out exogenous causes 1 and thyroid ultrasonography and possibly radioactive iodine uptake scan to distinguish between Graves' disease, toxic nodular goiter, and thyroiditis 3

For patients with TSH 0.1-0.45 mIU/L, monitoring with follow-up testing at 3-12 month intervals is recommended if repeat TSH remains in this range with normal free T4 and no signs or symptoms of cardiac disease or arrhythmias 3
Treatment is generally not required unless specific risk factors or symptoms are present 3
Special caution is needed with iodine exposure (e.g., radiographic contrast agents) in patients with known nodular thyroid disease, as this may exacerbate hyperthyroidism 3

Overlooking potential non-thyroidal causes of low TSH, such as medication effects or systemic illness 1
Failing to distinguish between subclinical and overt hyperthyroidism, which require different management approaches 2

Subclinical hyperthyroidism is diagnosed by measuring serum TSH, free T4, and total T3 or free T3, with the thyroid hormones remaining within their normal reference ranges 5
TSH measurement is the primary screening test, with subclinical hyperthyroidism defined as TSH below the lower limit of the reference range (0.45 mIU/L) 5
Free T4 must be measured and should be within the normal reference range to distinguish subclinical from overt hyperthyroidism 5, 6
Total T3 or free T3 must also be measured and remain within normal limits 6, 7

For patients with TSH 0.1-0.45 mIU/L, repeat TSH, FT4, and T3 measurements for confirmation, with timing depending on clinical context, such as atrial fibrillation, cardiac disease, or serious medical conditions, which should be retested within 2 weeks 6, 7
When risk factors are absent, repeat testing within 3 months is appropriate 6

Medication effects, such as dopamine, glucocorticoids, and possibly dobutamine, can suppress TSH 5
Nonthyroidal illness, or euthyroid sick syndrome, can suppress TSH, though undetectable TSH is rare unless glucocorticoids or dopamine are being administered 5
Normal pregnancy can cause physiologic TSH suppression, particularly in the first trimester 5
Recovery phase after hyperthyroidism treatment can cause transient low TSH 5
Central hypothyroidism is distinguished by low-normal FT4 rather than the high-normal FT4 typical of subclinical hyperthyroidism 5

The normal TSH reference range is 0.45-4.5 mIU/L based on the NHANES III survey of a disease-free population 5
A narrower upper limit of 2.5 mIU/L may be suggested, but the broader range avoids misidentifying normal individuals due to assay variability, TSH isoforms, or heterophilic antibodies 5, 8